Meridian Bioscience Inc (NASDAQ:VIVO)

14.35
Delayed Data
As of Apr 25
 +0.05 / +0.35%
Today’s Change
13.23
Today|||52-Week Range
16.45
+2.50%
Year-to-Date
No recent news for Meridian Bioscience Inc.

Today’s Trading

Previous close14.30
Today’s open14.25
Day’s range14.20 - 14.48
Volume141,949
Average volume (3 months)293,773
Market cap$636.7M
Data as of 4:00pm ET, 04/25/2018

Growth & Valuation

Earnings growth (last year)-32.89%
Earnings growth (this year)+5.33%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+2.39%
P/E ratio28.1
Price/Sales3.03
Price/Book3.75

Competitors

 Today’s
change
Today’s
% change
CALACalithera Bioscience...0.000.00%
LNTHLantheus Holdings In...-0.20-1.14%
----
OXFDOxford Immunotec Glo...+0.23+1.87%
Data as of 4:00pm ET, 04/25/2018

Financials

Last reporting dateApril 26, 2018
EPS forecast (this quarter)$0.21
Annual revenue (last year)$200.8M
Annual profit (last year)$21.6M
Net profit margin10.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John P. Kenny
Executive VP &
President-Global Operations
Lawrence J. Baldini
Corporate headquarters
Cincinnati, Ohio

Forecasts